Form 4: Boston Scientific Director John E. Sununu Receives Annual Equity Award

Director John E. Sununu received an annual equity award of 2,901 shares of Boston Scientific common stock on May 9, 2024.

Summary

• On May 9, 2024, John E. Sununu, a director of Boston Scientific Corp, received an annual equity award.
• The award consisted of 2,901 shares of common stock.
• These shares were granted as restricted stock, vesting fully upon the next annual meeting of stockholders.
• The value of the award is $215,000, calculated using the closing price of Boston Scientific common stock on the grant date.
• Following this transaction, Sununu directly owns 52,642 shares of Boston Scientific common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard compensation practice, indicating stability and alignment of interests.

Positives

• The equity award aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The restricted stock vests fully upon the next annual meeting of stockholders, incentivizing continued service.

Industry Context

Equity awards are a common practice in the healthcare industry to incentivize and retain key personnel, aligning their interests with those of the shareholders. Boston Scientific's approach appears consistent with industry norms.

Comparison to Industry Standards

• Many companies in the medical device industry, such as Medtronic and Abbott, use equity awards as part of their compensation packages for directors and executives.
• The size and vesting schedule of the award are likely benchmarked against peer companies to ensure competitiveness.
• The specific details of these awards are often disclosed in proxy statements and other SEC filings.

Stakeholder Impact

• Shareholders may view the equity award positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a sign of the company's commitment to its leadership.

Next Steps

• The granted shares will vest upon the next annual meeting of stockholders.

Key Dates